HEALTH PROFESSIONAL RESOURCES

 

COMMUNICABLE DISEASE UNIVERSAL RISK ASSESSMENT

Communicable Disease (HIV, Hep & STD) Risk Assessment Form (PDF format)

Communicable Disease (HIV, Hep & STD) Risk Assessment Form (Word Doc)

The Communicable Disease Unit within the Wyoming Department of Health (WDH) has released the comprehensive risk assessment (see hyperlink above) to support HIV, Hepatitis and STD screening. This risk assessment includes a two page patient intake form, a two page clinic use only section.  Additional documentation is included (HIPAA/informed consent form and the screening recommendations). 

The purpose of this risk assessment is to streamline recommended comprehensive screenings based on common risk and to assist providers with collecting variables required for reporting on all positive HIV, Hepatitis B & C and STD cases. This risk assessment is not a required document, however, the WDH has limited funds for communicable disease testing and will therefore support screening solely based on sufficient documentation of client risk. If client risk is sufficiently documented either on this risk assessment or the knowyo.org screening voucher, WDH is willing to supply federal funding for screening based on corresponding client risk(s). Please note: if proper risk cannot be documented, WDH will be unable to provide reimbursement for these screenings and clients will be responsible for covering the cost of testing. Please refer to the “Wyoming Department of Health Communicable Disease Screening Recommendations” to determine necessary screenings based on reported client risk.  

This document is being made available in word format so that clinics may manipulate it to fit individual clinic needs. Clinic-added content is welcome however, deleting fields may slow the reimbursement process

 

Communicable Disease Screening Recommendations

Notice of Privacy Practices

 

HEPATITIS REPORTING

Viral hepatitis is a reportable disease. All hepatitis cases are required to be reported to the Wyoming Department of Health (WDH).

Please report all Viral Hepatitis (B and C) cases electronically thru the Electronic Confidential Disease Report by clicking on the link below.

 ECDR 

 

Please contact the State CIDDC (307) 777-7953 prior to submitting electronically for additional required information.

All Hepatitis A reporting should be managed as indicated on the Wyoming Reportable Diseases and Conditions list found HERE.

Additional Hepatitis related questions may be directed to the Ashley Grajczyk, Hepatitis Program Coordinator at (307) 777-8005 or via email (click on name to send email or "email us" field in contact box).

 

 VIRAL HEPATITIS SURVEILLANCE HEIRARCHY

 

VIRAL HEPATITIS SCREENING RECOMMENDATIONS (WY DEPT. OF HEALTH)

Hepatitis B

  • Donors of blood, plasma, organs, tissues, or semen
  • Foreign Born from Asia, Africa, or South America
  • Health care, emergency medical, and public safety workers after needle sticks, sharps, or mucosal exposures to HBV-positive blood
  • Hemodialysis patients
  • History of incarceration
  • HIV-positive individuals
  • Household, needle-sharing, or sex contact of persons known to be HBsAg-positive
  • Infants born to HBsAg-positive mothers
  • Men who have sex with men (MSM)
  • Persons needing immunosuppressive therapy, including chemotherapy, immunosuppression related to organ transplantation and immunosuppression for rheumatologic or gastroenterologic disorders
  • Persons who have ever injected illegal drugs, including those who injected once or a few times many years ago and do not consider themselves as drug users
  • Persons with persistently elevated liver enzymes (ALT/AST) of unknown causation
  • Pregnant women
  • U.S. born persons not vaccinated as infants whose parent were born in regions with high HBV endemicity (Asia, Africa, South America)

Hepatitis C

  • Donors of blood, plasma, organs, tissues, or semen
  • Health care, emergency medical, and public safety workers after needle sticks, sharps, or mucosal exposures to HCV-positive blood
  • History of incarceration
  • HIV-positive individuals
  • Infants born to HCV-positive mothers
  • Long-term hemodialysis patients
  • Men who have sex with men (MSM)
  • Persons who have ever injected illegal drugs, including those who injected once or a few times many years ago and do not consider themselves as drug users
  • Persons who received clotting factor concentrates produced before 1987
  • Persons with a history of multiple sex partner or multiple sexually transmitted diseases
  • Persons with a history of tattooing or body piercing
  • Persons with chronic liver disease
  • Persons with persistently elevated liver enzymes (ALT/AST) of unknown causation
  • Pregnant women with high risk
  • Recipients of blood transfusions, blood components or organ transplants prior to July of 1992
  • Sex partners of HCV-positive persons
Referrences:

Centers for Disease Control and Prevention. Hepatitis C and Incarceration. May 2011. http://www.cdc.gov/hepatitis/HCV/PDFs/HepCIncarcerationFactSheet-BW.pdf

Centers for Disease Control and Prevention. Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus infection. MMWR 2008; 57(No.RR-8).

Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) and HCV-related chronic disease. MMWR 1998;47(No. RR-19).

Center for Disease Control. Recommendations for Routine Testing and Follow-up for Chronic Hepatitis B Virus (HBV) Infection. http://www.cdc.gov/hepatitis/HBV/PDFs/ChronicHepBTestingFlwUp.pdf

Centers for Disease Control and Prevention. Sexual Transmission of Hepatitis C Virus Among HIV-Infected Men Who Have Sex With Men – New York City, 2005-2010. MMWR 2011; 60 (No. 28).

Centers for Disease Control and Prevention. Travellers’ Health; Yellow Book. http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/hepatitis-b.htm

CLICK HERE for a PDF version of these Screening Recommendations.

 

 

HELPFUL LINKS

American Liver Foundation:  www.liverfoundation.org

This website provides information on liver diseases, advocacy for education, treatment and research funding.

 

National Alliance of State and Territorial AIDS Directors (NASTAD):  http://www.nastad.org/viral_hepatitis/default.aspx

An important resource for information about hepatitis integration, legislative updates that impact viral hepatitis, advocacy issues and other important topics.

 

National Viral Hepatitis Round Table:  www.nvhr.org

A coalition of public, private, and voluntary organizations dedicated to reducing the incidence of infection, morbidity, and mortality from viral hepatitis in the US through strategic planning, leadership, advocacy, and research.

 

Hepatitis Web Study:  http://depts.washington.edu/hepstudy/

This website provides interactive, case-based modules related to the clinical care of persons with viral hepatitis.

 

American Gastroenterological Association:  www.gastro.org

This is the website for the professional association of gastroenterologists and its purpose is to advance the science and practice of gastroenerology.

 

American Association for the study of Liver Disease:  www.aasld.org

AASLD is a non-profit, member organization for physicians and others striving to prevent and cure diseases of the liver.

 

HCV University:  www.hcvu.org

Hep C University is an educational website designed for providers seeking to learn the latest information on the treatment of Hepatitis C.

Hepatitis B Immune Globuline (Intravenous):  http://www.hepagamb.com

Cangene Corporation offers a Hepatitis B post-exposure prophylaxis called HepaGam B. Reimbursement support is available for health care providers, medical billing staff and patients by contacting 1-877-HepaGam (437-2426).  Visit the Acquisition and Reimbursement tab to learn more

 

HARM REDUCTION

Harm Reduction Coalition:  www.harmreduction.org

The Harm Reduction Coalition is committed to reducing drug-related harm among individuals and communities by initiating and promoting harm reduction education, interventions and community organizing.

 

Harm Reduction Journal:  www.harmreductionjournal.org

Harm Reduction Journal is an open access, peer-reviewed, online journal whose focus is prevalent patterns of psychoactive drug use, the public policies meant to control them, and the search for effective methods of reducing the adverse medical, public health, and social consequences associated with both the drugs and the drug policies.

One & Only Campaign:  http://www.oneandonlycampaign.org

"One Needle, One Syringe, Only One Time"  The One & Only Campaign is a public health campaign, led by the Centers for Disease Control and Prevention (CDC) and the Safe Injection Practices Coalition (SIPC), to raise awareness among patients and healthcare providers about safe injection practices. The campaign aims to eradicate outbreaks resulting from unsafe injection practices.  Click here for additional SIPC provider resources.